Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies

被引:0
|
作者
Flemming, Juliana [1 ]
Wiesen, Lisa [1 ]
Herschhorn, Alon [1 ]
机构
[1] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Room 2-101 MRF,689 23rd Ave SE, Minneapolis, MN 55455 USA
关键词
HIV-1; entry; HIV-1 envelope glycoproteins; conformational transitions; broadly neutralizing antibodies; HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL-REGION; HUMAN MONOCLONAL-ANTIBODIES; GP120 INNER DOMAIN; CD4; BINDING-SITE; CD4-BOUND CONFORMATION; POTENT NEUTRALIZATION; GP41-GP120; INTERFACE; STRUCTURAL BASIS; TYPE-1; ENVELOPE;
D O I
10.1089/aid.2018.0102
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV type 1 (HIV-1) envelope glycoproteins (Env) mediate virus entry and are the target of neutralizing antibodies. Binding of the metastable HIV-1 Env trimer to the CD4 receptor triggers structural rearrangements that mediate Env conformational transitions from a closed conformation to a more open state through an intermediate step. Recent studies have revealed new insights on the dynamics, regulation, and molecular mechanisms of Env transitions along the entry pathway. In this study, we provide an overview of the current knowledge on Env conformational dynamics and the relationship between Env conformational states and neutralization selectivity of the broadly neutralizing antibodies that develop in 10%-20% of infected individuals and may provide guidance for the development of an effective HIV-1 vaccine.
引用
收藏
页码:794 / 803
页数:10
相关论文
共 50 条
  • [31] Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
    Zhang, Zhiqing
    Li, Shaowei
    Gu, Ying
    Xia, Ningshao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)
  • [32] Broadly neutralizing antibodies: An approach to control HIV-1 infection
    Yaseen, Mahmoud Mohammad
    Yaseen, Mohammad Mahmoud
    Alqudah, Mohammad Ali
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2017, 36 (01) : 31 - 40
  • [33] Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
    Awan, Seemal F.
    Happe, Myra
    Hofstetter, Amelia R.
    Gama, Lucio
    CURRENT OPINION IN HIV AND AIDS, 2022, 17 (04) : 247 - 257
  • [34] HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies
    Misra, Milind
    Jeffy, Jeffy
    Liao, Charis
    Pickthorn, Stephanie
    Wagh, Kshitij
    Herschhorn, Alon
    BIOINFORMATICS, 2024, 40 (03)
  • [35] Role of Broadly Neutralizing Antibodies in the Controlling of HIV-1 Infection
    Yildirmak, Taner
    KLIMIK JOURNAL, 2019, 32 (02) : 112 - 116
  • [36] Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
    Liu, Yubin
    Cao, Wei
    Sun, Ming
    Li, Taisheng
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 194 - 206
  • [37] Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
    van Gils, Marit J.
    Sanders, Rogier W.
    VIROLOGY, 2013, 435 (01) : 46 - 56
  • [38] Broadly neutralizing antibodies against HIV-1 and concepts for application
    Gruell, Henning
    Schommers, Philipp
    CURRENT OPINION IN VIROLOGY, 2022, 54
  • [39] Neutralizing antibodies decrease the envelope fluidity of HIV-1
    Harada, Shinji
    Monde, Kazuaki
    Tanaka, Yuetsu
    Kimura, Tetsuya
    Maeda, Yosuke
    Yusa, Keisuke
    VIROLOGY, 2008, 370 (01) : 142 - 150
  • [40] Centralized HIV-1 envelope immunogens and neutralizing antibodies
    Gao, Feng
    Liao, Hua-Xin
    Hahn, Beatrice H.
    Letvin, Norman L.
    Korber, Bette T.
    Haynes, Barton F.
    CURRENT HIV RESEARCH, 2007, 5 (06) : 572 - 577